Back to BCAX
Aisling Capital Management LP → BCAX
Aisling Capital Management LP BCAX Position History
Bicara Therapeutics Inc. • Healthcare
Quarters held
4
Latest value
$10.2M
Q3 2026
Peak value
$16.9M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $9.6M |
| Q1 2026 | $11.3M |
| Q2 2026 | $16.9M |
| Q3 2026 | $10.2M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $10.2M | 548.9K | — | — |
| Q2 2026 | $16.9M | 568.9K | — | — |
| Q1 2026 | $11.3M | 568.9K | — | — |
| Q4 2025 | $9.6M | 568.9K | — | — |
Other funds holding BCAX
Other Aisling Capital Management LP positions
BBIO
$389.3MBridgeBio Pharma Inc. (BBIO)
BBIO
$378MBridgeBio Pharma Inc. (BBIO)
BBIO
$341.8MBRIDGEBIO PHARMA INC
BBIO
$203.3MBRIDGEBIO PHARMA INC
MNST
$37.6MMONTE ROSA THERAPEUTICS INC
SNDX
$30.8MSyndax Pharmaceuticals, Inc. (SNDX)
SNDX
$28.8MSYNDAX PHARMACEUTICALS INC
SNDX
$27.7MSyndax Pharmaceuticals, Inc. (SNDX)